SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 40 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $237,703 | -52.1% | 141,000 | -45.1% | 0.02% | -51.4% |
| Q1 2023 | $496,500 | -40.1% | 257,000 | -42.1% | 0.04% | -34.0% |
| Q4 2022 | $829,392 | +112.1% | 444,000 | +88.9% | 0.05% | +103.8% |
| Q3 2022 | $391,000 | -97.5% | 235,000 | -96.3% | 0.03% | -97.7% |
| Q4 2020 | $15,722,000 | +18.2% | 6,412,000 | -0.1% | 1.12% | -2.3% |
| Q3 2020 | $13,306,000 | +12.2% | 6,418,000 | +24.2% | 1.15% | +10.6% |
| Q2 2020 | $11,858,000 | +159.4% | 5,167,000 | +71.7% | 1.04% | +157.6% |
| Q1 2020 | $4,572,000 | -38.2% | 3,009,000 | -20.9% | 0.40% | -18.1% |
| Q4 2019 | $7,397,000 | +46.9% | 3,803,000 | -0.2% | 0.49% | +34.1% |
| Q3 2019 | $5,034,000 | -39.8% | 3,810,000 | +1.5% | 0.37% | -40.9% |
| Q2 2019 | $8,356,000 | +22.7% | 3,754,000 | -0.5% | 0.62% | +8.9% |
| Q1 2019 | $6,808,000 | – | 3,772,000 | – | 0.57% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 8,907,000 | $17,329,459 | 1.40% |
| CSS LLC/IL | 7,106,000 | $13,798,218 | 0.91% |
| Aequim Alternative Investments LP | 5,000,000 | $9,672,055 | 0.31% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 5,948,000 | $11,571,045 | 0.23% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,051,000 | $3,989,195 | 0.11% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 7,080,000 | $13,695,632 | 0.07% |
| Point72 Asset Management, L.P. | 9,007,000 | $17,447,371 | 0.05% |
| SSI INVESTMENT MANAGEMENT LLC | 257,000 | $496,500 | 0.04% |
| LORD, ABBETT & CO. LLC | 3,097,000 | $5,983 | 0.02% |
| D. E. Shaw & Co., Inc. | 4,100,000 | $7,953,192 | 0.01% |